Abstract:BACKGROUND: Interstitial lung disease (ILD) is associated with substantial morbidity and mortality, which is one of the key systematic manifestations of connective tissue disease (CTD). Tripterygium wilfordii, known as Leigongteng in Chinese, has been applied to treat connective tissue disease-related interstitial lung disease (CTD-ILD) for many years. Triptolide is a key effective component from Tripterygium wilfordii. But the molecular mechanism of Triptolide for treating CTD-ILD is not yet clear.METHODS: Gaining insight into the molecular mechanism of Triptolide intervention CTD-ILD, we used the method of network pharmacology. And then we conducted drug-target networks to analyse the potential protein targets between Triptolide and CTD-ILD. Finally, AutoDock Vina was selected for molecular docking.RESULTS: By analysing the interaction genes between Triptolide and CTD-ILD, 242 genes were obtained. The top 10 targets of the highest enrichment scores were STAT3, AKT1, MAPK1, IL6, TP53, MAPK3, RELA, TNF, JUN, JAK2. GO and KEGG enrichment analysis exhibited that multiple signalling pathways were involved. PI3K-Akt, multiple virus infections, cancer signalling, chemokine, and apoptosis signalling pathway are the main pathways for Triptolide intervention CTD-ILD. And it is related to various biological processes such as inflammation, infection, cell apoptosis, and cancer. Molecular docking shows Triptolide can bind with its target protein in a good bond by intermolecular force.CONCLUSIONS: This study preliminarily reveals the internal molecular mechanism of Triptolide interfere with CTD-ILD through multiple targets, multiple access, validated through molecular docking.KEY MESSAGESTriptolide intervention CTD-ILD, which are related to various biological processes such as inflammation, infection, cell apoptosis, and cancer.PI3K-Akt, multiple virus infections, and apoptosis signalling pathway are the main pathways for Triptolide intervention CTD-ILD.Triptolide can bind with related target protein in a good bond by Intermolecular force, exhibiting a good docking activity.

Selection of Triptolide Ligands from a Random Phage Display Library and Primary Verification of Their Combination

Computational prediction and experimental validation of low-affinity target of triptolide and its analogues

Identification of in vivo and in vitro metabolites of triptolide by liquid chromatography-tandem mass spectrometry

Preparation of sensitive monoclonal antibodies against triptolide and establishment of a rapid and cost-effective icELISA method for authentication of Tripterygium wilfordii and related products

Triptolide: Medicinal chemistry, chemical biology and clinical progress

Leveraging computational tools to understand the triptolide-XPB interaction

Metabolic profiling of triptophenolide in rat plasma, urine, bile and faeces after intragastric administration

The mechanism of triptolide in the treatment of connective tissue disease-related interstitial lung disease based on network pharmacology and molecular docking

Triptolide: pharmacological spectrum, biosynthesis, chemical synthesis and derivatives

Screening anti-tumor compounds from Ligusticum wallichii using cell membrane chromatography combined with high-performance liquid chromatography and mass spectrometry.

Selection of Trypsin Inhibitors in Phage Peptide Library

Broad targeting of triptolide to resistance and sensitization for cancer therapy

Tandemly duplicated CYP82Ds catalyze 14-hydroxylation in triptolide biosynthesis and precursor production in Saccharomyces cerevisiae

The Yin and Yang of the Natural Product Triptolide and Its Interactions with XPB, an Essential Protein for Gene Expression and DNA Repair

TAB1: a Target of Triptolide in Macrophages.

Ph-Sensitive Nanoformulated Triptolide As a Targeted Therapeutic Strategy for Hepatocellular Carcinoma.

Hydrophilic Interaction Liquid Chromatography-Solid Phase Extraction Directly Combined with Protein Precipitation for the Determination of Triptorelin in Plasma.

Triptolide synergistically enhances antitumor activity of oxaliplatin in colon carcinoma in vitro and in vivo

Synchronous Measuring of Triptolide Changes in Rat Brain and Blood and Its Application to a Comparative Pharmacokinetic Study in Normal and Alzheimer's Disease Rats.

Triptolide Shows High Sensitivity and Low Toxicity Against Acute Myeloid Leukemia Cell Lines Through Inhibiting WSTF-RNAPII Complex

Analysis of Triptophenolide and Its Related Compounds from Tripterygium Wilfordii Hook.F by Electrospray Ionization Tandem Mass Spectrometry